Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Before-and-after progress should be viewed as a pattern, not a single number
Lasts for a few seconds to a minute and can recur over a period of days or weeks
STARTER DOSE 3 mg STRENGTH 3 mg d NDC NUMBER 0169-4303-30 BOTTLE QUANTITY 30 x 3 mg per bottle THERAPEUTIC DOSE 7 mg STRENGTH 7 mg NDC NUMBER 0169-4307-30 BOTTLE QUANTITY 30 x 7 mg per bottle THERAPEUTIC DOSE 14 mg STRENGTH 14 mg NDC NUMBER 0169-4314-30 BOTTLE QUANTITY 30 x 14 mg per bottle d The 3 mg dose is intended for treatment initiation and is not effective for glycemic control
The JourneyLite team can help you understand whether gastric sleeve, gastric bypass, or another treatment is the best fit
Mean change in HbA1c from baseline at week 40 was -22 percentage points with semaglutide 20 mg and -19 percentage points with semaglutide 10 mg (estimated treatment difference [ETD] -023 percentage points [95% CI -036 to -011]
